Table 2 Free drug content, Total drug content and %EE of SLN formulationsange
From: Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine
| S. No. | Formulation | Free drug content (mg) | Total drug content (mg) | %EE |
|---|---|---|---|---|
| 1 | F1 | 10.2 | 20.136 | 48.84 |
| 2 | F2 | 23.4 | 34.86 | 32.87 |
| 3 | F3 | 8.6 | 25.8 | 66.7 |
